Femoston Conti 1 mg/5 mg Tablet

Femoston Conti 1 mg/5 mg Tablet is a hormone replacement therapy (HRT) used to treat postmenopausal symptoms and prevent osteoporosis (weak and brittle bones) caused by menopause in women. Post-menopause is a condition in which women have not had a period for 12 months or more. During menopause, estrogen levels decrease, leading to hot flushes (feeling of heat over the face, neck, and chest). Women with menopause are at risk of developing osteoporosis (thinning of bones). Femoston Conti 1 mg/5 mg Tablet can be used to prevent osteoporosis after menopause. Osteoporosis is a bone disease that weakens and thins bones by decreasing bone density which is common in post-menopausal women. 

Femoston Conti 1 mg/5 mg Tablet contains two female hormones, Estradiol and Dydrogesterone. Estradiol works by replacing the falling levels of estrogen in the body and thus helps to reduce menopause symptoms. Dydrogesterone works by reducing the overgrowth of the womb lining. Together, Femoston Conti 1 mg/5 mg Tablet helps treat postmenopausal symptoms and osteoporosis.

Femoston Conti 1 mg/5 mg Tablet should be taken as advised by your doctor. The dose of medicine and duration of treatment will be decided by the doctor based on your medical condition. Femoston Conti 1 mg/5 mg Tablet may cause certain side effects such as stomach pain, headache, breast pain or tenderness and back pain. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor. 

Femoston Conti 1 mg/5 mg Tablet should be avoided if you are allergic to it or if you have a history of breast cancer, endometrial cancer (cancer of the lining of the womb), unexplained vaginal bleeding, untreated endometrial hyperplasia (thickening of the womb lining), blood clotting disorder, heart attack or angina (chest pain), inherited porphyria (a blood disorder) or liver disease. It is not recommended for use in pregnant and breastfeeding women. Stop taking Femoston Conti 1 mg/5 mg Tablet and consult your doctor immediately if you develop jaundice (yellowing of the skin and eyes), high blood pressure and migraine-like headache, become pregnant or notice signs of a blood clot such as redness, swelling and pain in the legs, sudden chest pain or difficulty in breathing. Inform your doctor if you have any intolerance to sugar.

Femoston Conti 1 mg/5 mg Tablet contains Estradiol and Dydrogesterone used to treat postmenopausal symptoms and prevent osteoporosis (weak and brittle bones) caused by menopause in women. Estradiol restores the falling levels of estrogen in the body and thus helps to reduce menopause symptoms. Dydrogesterone decreases the overgrowth of the womb lining. Also, Femoston Conti 1 mg/5 mg Tablet is used as prophylaxis in preventing osteoporosis in postmenopausal women and prevents bone loss and fractures.

Before starting treatment with Femoston Conti 1 mg/5 mg Tablet , inform your doctor if you are allergic to it. Avoid taking Femoston Conti 1 mg/5 mg Tablet if you are pregnant or breastfeeding. Femoston Conti 1 mg/5 mg Tablet is not recommended for children. If you have premature menopause, inform your doctor before taking Femoston Conti 1 mg/5 mg Tablet so that the risks and benefits may be compared. Avoid taking Femoston Conti 1 mg/5 mg Tablet if you have recently had a stroke, heart attack or angina (chest pain), liver disease and untreated endometrial hyperplasia (thickening of the womb lining). If you have very high levels of fat (triglycerides) in your blood, inform your doctor before taking Femoston Conti 1 mg/5 mg Tablet . You are recommended to avoid alcohol consumption with Femoston Conti 1 mg/5 mg Tablet as it may increase the risk of breast cancer. If you experience sudden chest pain, difficulty breathing, or painful swelling and redness of your legs, stop taking Femoston Conti 1 mg/5 mg Tablet and consult a doctor immediately, as these might be signs of a blood clot. Long-term use and high dosages of this medication may raise your risk of heart attack, stroke, blood clots, breast cancer, or uterine cancer. Hence discuss this risk with your doctor before taking Femoston Conti 1 mg/5 mg Tablet .

• Regular breast screening is recommended while taking Femoston Conti 1 mg/5 mg Tablet .
• Check your breasts regularly for any changes in the nipple, dimpling of the skin or any lumps.
• While giving blood for tests, inform your doctor that you are taking Femoston Conti 1 mg/5 mg Tablet as this medicine may affect some test results.